Vaccine specific T cells in IL-2/CD25 fusion protein treated mice expressed higher levels of Granzyme B as well as IFN-γ, showed a less exhausted phenotype and facilitated an improved anti-tumor immune response. The gene discussed is IL2; the disease is neoplasm.